Sagespring Wealth Partners’s Thermo Fisher Scientific TMO Stock Holding History

Sagespring Wealth Partners’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.92M	Sell	3,837 -558	-13%	-$268K	0.03%	221
2026 Q1	$2.16M	Sell	4,395 -507	-10%	-$275K	0.04%	186
2025 Q4	$2.84M	Buy	4,902 +1,193	+32%	+$675K	0.05%	158
2025 Q3	$1.8M	Buy	3,709 +1,246	+51%	+$580K	0.04%	199
2025 Q2	$999K	Sell	2,463 -650	-21%	-$272K	0.02%	282
2025 Q1	$1.55M	Buy	3,113 +725	+30%	+$393K	0.04%	185
2024 Q4	$1.24M	Buy	+2,388	New	+$1.31M	0.03%	191

Other funds holding TMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Sagespring Wealth Partners's TMO Position: Q2 2026 in Review

Sagespring Wealth Partners reduced its Thermo Fisher Scientific (TMO) stake by 13% in Q2 2026, selling an estimated $268K and leaving 3,837 shares worth $1.92M. The position accounts for 0.03% of the portfolio, ranked #221.

Sagespring Wealth Partners first reported a position in TMO in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.84M in Q4 2025. 2,623 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

Sagespring Wealth Partners held 3,837 shares of Thermo Fisher Scientific worth $1.92M as of Q2 2026.
Sagespring Wealth Partners sold 558 Thermo Fisher Scientific shares in Q2 2026, an estimated $268K.
Thermo Fisher Scientific made up 0.03% of Sagespring Wealth Partners's portfolio in Q2 2026, its #221 holding.
Sagespring Wealth Partners first reported a position in Thermo Fisher Scientific in Q4 2024 and has held it in 7 quarters since.
Sagespring Wealth Partners's Thermo Fisher Scientific position peaked at $2.84M in Q4 2025.
2,623 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Sagespring Wealth Partners's 13F filing for Q2 2026, filed 3 Aug 2026.